Evaluating the anticancer properties of VAF: a novel folate-α-tocopherol conjugate against lung cancer cells

According to the research, VAF reduces the possibility of adverse effects while increasing the efficacy of anticancer treatments. The compound exhibits promising properties that make it a great option for additional research and development in cancer treatments. Research provides important new information about drug-targeting delivery systems and improves a potentially useful method for anticancer drug therapeutic indices.